University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- To Heal Skin, Scientists Invent Living Bioelectronics.
- Register for Children’s Specialized Hospital Distinguished Lecture on 8/14
- Researchers Shed Light on Cause of ‘Happy Hypoxia’ in COVID-19 Patients.
- Upending Conventional Wisdom, Cannabis Use Doesn’t Hinder PTSD Therapy.
- Many Firearm Owners Can’t Recognize When a Cable Lock Is Properly Installed.
Categories
- Community (1,944)
- Covid (971)
- CTO Events (1)
- News (2,488)
- Pilots (20)